Literature DB >> 20738762

Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromsø Study.

A Vik1, E B Mathiesen, J Brox, T Wilsgaard, I Njølstad, L Jørgensen, J-B Hansen.   

Abstract

BACKGROUND: Previous studies have reported conflicting results on the relation between serum osteoprotegerin (OPG) concentration and carotid intima media thickness (CIMT). PATIENTS/
METHODS: The present study was conducted to investigate the relations between OPG, risk factors for cardiovascular diseases (CVD) and carotid intima media thickness (CIMT) in a large cross-sectional study including 6516 subjects aged 25-85years who participated in a population-based health survey.
RESULTS: CIMT increased significantly across tertiles of OPG after adjustment for traditional cardiovascular risk factors such as age, gender, smoking, total cholesterol, high-density lipoprotein (HDL) cholesterol, C-reactive protein (CRP), body mass index (BMI), systolic blood pressure, CVD and diabetes mellitus (P<0.0001). There was a significant interaction between age and OPG (P=0.026). The risk of being in the uppermost quartile of CIMT was reduced (OR 0.52, 95% CI 0.30-0.88) with each standard deviation (SD) higher level of OPG in subjects <45years (n=444), whereas subjects ≥55years of age (n=4884) had an increased risk of being in the uppermost quartile of CIMT (OR 1.19, 95% CI 1.10-1.29) after adjustment for traditional CVD risk factors.
CONCLUSIONS: Age has a differential impact on the association between OPG and CIMT in a general population. The present findings may suggest that increased serum OPG does not promote early atherosclerosis in younger subjects.
© 2010 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20738762     DOI: 10.1111/j.1538-7836.2010.03990.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  15 in total

1.  Predictors of vascular remodelling in hypertensive subjects with well-controlled blood pressure levels.

Authors:  M Puato; M Rattazzi; M Zanon; E Benetti; E Faggin; P Palatini; P Pauletto
Journal:  J Hum Hypertens       Date:  2014-12-18       Impact factor: 3.012

2.  Noninvasive assessment of subclinical atherosclerosis in normotensive gravidae with gestational diabetes.

Authors:  A E Atay; H Simsek; B Demir; M N Sakar; M Kaya; S Pasa; S Demir; D Sit
Journal:  Herz       Date:  2013-07-18       Impact factor: 1.443

3.  Impact of hypertension on vascular remodeling in patients with psoriatic arthritis.

Authors:  M Puato; R Ramonda; A Doria; M Rattazzi; E Faggin; G Balbi; M Zanon; M Zanardo; C Tirrito; M Lorenzin; V Modesti; M Plebani; M Zaninotto; L Punzi; P Pauletto
Journal:  J Hum Hypertens       Date:  2013-07-11       Impact factor: 3.012

4.  9- and 13-HODE regulate fatty acid binding protein-4 in human macrophages, but does not involve HODE/GPR132 axis in PPAR-γ regulation of FABP4.

Authors:  Venkat Vangaveti; Venkatesh Shashidhar; Fiona Collier; Jason Hodge; Catherine Rush; Usman Malabu; Bernhard Baune; Richard Lee Kennedy
Journal:  Ther Adv Endocrinol Metab       Date:  2018-02-27       Impact factor: 3.565

5.  Serum Osteoprotegerin and Carotid Intima-Media Thickness Are Related to High Arterial Stiffness in Heart Failure with Reduced Ejection Fraction.

Authors:  Lajos Fehérvári; Attila Frigy; Lóránd Kocsis; István Adorján Szabó; Timea Magdolna Szabo; Melinda Urkon; Zita Jakó; Előd Ernő Nagy
Journal:  Diagnostics (Basel)       Date:  2021-04-24

6.  Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis.

Authors:  Constantinos Giaginis; Aikaterini Papadopouli; Athina Zira; Athanasios Katsargyris; Christos Klonaris; Stamatios Theocharis
Journal:  Med Sci Monit       Date:  2012-10

7.  Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men.

Authors:  Weena J Y Chen; Luuk J Rijzewijk; Rutger W van der Meer; Martijn W Heymans; Eelco van Duinkerken; Mark Lubberink; Adriaan A Lammertsma; Hildo J Lamb; Albert de Roos; Johannes A Romijn; Jan W A Smit; Jeroen J Bax; Mette Bjerre; Jan Frystyk; Allan Flyvbjerg; Michaela Diamant
Journal:  Cardiovasc Diabetol       Date:  2011-07-19       Impact factor: 9.951

Review 8.  Prevalence of high blood pressure in 122,053 adolescents: a systematic review and meta-regression.

Authors:  Augusto César Ferreira de Moraes; Maria Beatriz Lacerda; Luis A Moreno; Bernardo L Horta; Heráclito Barbosa Carvalho
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

9.  Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes.

Authors:  Yixin Niu; Weiwei Zhang; Zhen Yang; Xiaoyong Li; Jie Wen; Suijun Wang; Hongmei Zhang; Xuanchun Wang; Houguang Zhou; Wenjun Fang; Li Qin; Qing Su
Journal:  BMC Cardiovasc Disord       Date:  2015-08-11       Impact factor: 2.298

10.  Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.

Authors:  Panagiotis Pateinakis; Aikaterini Papagianni; Stella Douma; Georgios Efstratiadis; Dimitrios Memmos
Journal:  BMC Nephrol       Date:  2013-06-12       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.